This is a competitive renewal for the 21st to 25th years of an interdisciplinary postdoctoral program providing training in basic and clinical research in the pharmacology, physiology and neurobiology of drug abuse. This training program has a long and distinguished history. The Mount Sinai School of Medicine has always been a major and vibrant research center. We have recently undergone a dramatic growth in physical facilities and research programs. The training program has been revised to maintain its historical strengths and to take advantage of these new physical, educational, programmatic and intellectual resources of the school. The goals of our program are 1. Attract the finest young biomedical and clinical researchers to careers in drug abuse research. 2. Encourage faculty to pursue research relevant to drug abuse. 3. Train fellows in cutting-edge drug abuse research. 4. Facilitate the career development of trainees. To achieve these goals we have developed an extensive recruitment program, a rich training curriculum and a strong mentoring and tracking structure. We have endeavored to design a program that will train researchers who will provide significant advances in the basic understanding and treatment of this important social and medical problem. Towards that end, we have revised our steering committee and faculty so that they are now composed of both basic and clinical researchers and we have revised our program to provide both basic science and clinical training for both scientists and physicians. We offer either basic science or clinical research training for 6 postdoctoral trainees. In addition to the laboratory environment and mentor, the training program includes courses in Research in Drug Abuse and Responsible Conduct in Research, a Drug Abuse Colloquium/Journal Club, a Drug Abuse Visiting Scholar and Seminar program, an annual Training Program Retreat, mentoring by a secondary advisor and Trainee Advisory Committee, participation in courses and presentations at the medical school, and travel to national meetings. We have assembled a world-class, broad-based interdisciplinary training faculty. The institution provides a fertile environment for this training program as well as specific resources to enhance this important educational endeavor.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Institutional National Research Service Award (T32)
Project #
5T32DA007135-22
Application #
6515449
Study Section
Human Development Research Subcommittee (NIDA)
Program Officer
Babecki, Beth
Project Start
1979-12-01
Project End
2006-06-30
Budget Start
2002-07-01
Budget End
2003-06-30
Support Year
22
Fiscal Year
2002
Total Cost
$240,718
Indirect Cost
Name
Mount Sinai School of Medicine
Department
Pharmacology
Type
Schools of Medicine
DUNS #
114400633
City
New York
State
NY
Country
United States
Zip Code
10029
Mazzone, C M; Pati, D; Michaelides, M et al. (2018) Acute engagement of Gq-mediated signaling in the bed nucleus of the stria terminalis induces anxiety-like behavior. Mol Psychiatry 23:143-153
Rabin, Rachel A; Dermody, Sarah S; George, Tony P (2018) Changes in tobacco consumption in cannabis dependent patients with schizophrenia versus non-psychiatric controls during 28-days of cannabis abstinence. Drug Alcohol Depend 185:181-188
Lueptow, Lindsay M; Devi, Lakshmi A; Fakira, Amanda K (2018) Targeting the Recently Deorphanized Receptor GPR83 for the Treatment of Immunological, Neuroendocrine and Neuropsychiatric Disorders. Prog Mol Biol Transl Sci 159:1-25
Alia-Klein, Nelly; Preston-Campbell, Rebecca N; Moeller, Scott J et al. (2018) Trait anger modulates neural activity in the fronto-parietal attention network. PLoS One 13:e0194444
Miller, M L; Ren, Y; Szutorisz, H et al. (2018) Ventral striatal regulation of CREM mediates impulsive action and drug addiction vulnerability. Mol Psychiatry 23:1328-1335
Bachi, Keren; Sierra, Salvador; Volkow, Nora D et al. (2017) Is biological aging accelerated in drug addiction? Curr Opin Behav Sci 13:34-39
Lueptow, Lindsay M (2017) Novel Object Recognition Test for the Investigation of Learning and Memory in Mice. J Vis Exp :
Obiorah, Ifeanyi V; Muhammad, Hamza; Stafford, Khalifa et al. (2017) THC Treatment Alters Glutamate Receptor Gene Expression in Human Stem Cell-Derived Neurons. Mol Neuropsychiatry 3:73-84
Michaelides, Michael; Miller, Michael L; DiNieri, Jennifer A et al. (2017) Dopamine D2 Receptor Signaling in the Nucleus Accumbens Comprises a Metabolic-Cognitive Brain Interface Regulating Metabolic Components of Glucose Reinforcement. Neuropsychopharmacology 42:2365-2376
Smith, Alexander C W; Scofield, Michael D; Heinsbroek, Jasper A et al. (2017) Accumbens nNOS Interneurons Regulate Cocaine Relapse. J Neurosci 37:742-756

Showing the most recent 10 out of 115 publications